4,4'-[1,5-pentanediylbis(oxy)]bisbenzenecarboxamidine dimethylsulphonate
- CAS No.
- 6823-79-6
- Chemical Name:
- 4,4'-[1,5-pentanediylbis(oxy)]bisbenzenecarboxamidine dimethylsulphonate
- Synonyms
- Lomidine;pentamidine mesylate;Pentamidine dimesylate;PENTAMIDINE DIMETHANESULFONATE;4,4'-[1,5-pentanediylbis(oxy)]bisbenzenecarboxamidine dimethylsulphonate
- CBNumber:
- CB5890857
- Molecular Formula:
- C21H32N4O8S2
- Molecular Weight:
- 532.63078
- MDL Number:
- MFCD01667908
- MOL File:
- 6823-79-6.mol
FDA UNII | 863QBB4D0A |
---|
4,4'-[1,5-pentanediylbis(oxy)]bisbenzenecarboxamidine dimethylsulphonate Chemical Properties,Uses,Production
Uses
Pentamidine (MP-601205) dimesylate is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine dimesylate inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine dimesylate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine dimesylate has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities[1][2][3][4].
in vivo
Pentamidine (0.25 mg/mouse; intramuscular injection; every 2 days; for 4 weeks; athymic nude mice) dimesylate treatment markedly inhibits the growth of WM9 human melanoma tumors in nude mice[1].
Animal Model: | Athymic nude mice (6 weeks old) injected with WM9 cells[1] |
Dosage: | 0.25 mg/mouse |
Administration: | Intramuscular injection; every 2 days; for 4 weeks |
Result: | Markedly inhibited the growth of WM9 human melanoma tumors in nude mice. |
IC 50
Trypanosoma; Leishmania
References
[1] Pathak MK, et al. Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. Mol Cancer Ther. 2002 Dec;1(14):1255-64. PMID:12516958
[2] Nguewa, P.A., et al., Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin. Chem Biodivers, 2005. 2(10): p. 1387-400. DOI:10.1002/cbdv.200590111
[3] Sands M, et al. Pentamidine: a review. Rev Infect Dis. 1985 Sep-Oct;7(5):625-34. DOI:10.1093/clinids/7.5.625
[4] David C. Bean, et al. Pentamidine: a drug to consider re-purposing in the targeted treatment of multi-drug resistant bacterial infections? J Lab Precis Med 2017;2:49.
4,4'-[1,5-pentanediylbis(oxy)]bisbenzenecarboxamidine dimethylsulphonate Preparation Products And Raw materials
Raw materials
Preparation Products
4,4'-[1,5-pentanediylbis(oxy)]bisbenzenecarboxamidine dimethylsulphonate Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +17819995354 | marketing@targetmol.com | United States | 32285 | 58 |
TargetMol Chemicals Inc. | +17819995354 | marketing@targetmol.com | United States | 19904 | 58 |
Shaanxi Dideu Newmaterial Co., Ltd. | 029-87576359 15353716720 | 1039@dideu.com | China | 9936 | 58 |
TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 21356 | 58 |
Supplier | Advantage |
---|---|
TargetMol Chemicals Inc. | 58 |
TargetMol Chemicals Inc. | 58 |
Shaanxi Dideu Newmaterial Co., Ltd. | 58 |
TargetMol Chemicals Inc. | 58 |
View Lastest Price from 4,4'-[1,5-pentanediylbis(oxy)]bisbenzenecarboxamidine dimethylsulphonate manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2024-10-24 | Pentamidine dimesylate
6823-79-6
|
US $1520.00-2500.00 / mg | 10g | TargetMol Chemicals Inc. |
-
- Pentamidine dimesylate
6823-79-6
- US $1520.00-2500.00 / mg
- TargetMol Chemicals Inc.